We are live on ! Find out more
PAPAIJV

Paragon Associates & Paragon Associates II Joint Venture Portfolio holdings

AUM $73.6M
1-Year Est. Return 61.93%
This Fund
S&P 500
This Quarter Est. Return
-20.61%
1 Year Est. Return
+61.93%
3 Year Est. Return
+167.56%
5 Year Est. Return
+341.85%
10 Year Est. Return
+2,192.73%
AUM
$93.1M
AUM Growth
-$84.9M
Cap. Flow
-$49.8M
Cap. Flow %
-53.49%
Top 10 Hldgs %
97.07%
Holding
21
New
3
Increased
1
Reduced
2
Closed
8

Top Buys

Rank Stock Value
1
QQQ icon
Invesco QQQ Trust
QQQ
+$12.7M
2
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$11.4M
3
CF icon
CF Industries
CF
+$2.79M
4
NVGS icon
Navigator Holdings
NVGS
+$2.02M

Top Sells

Rank Stock Value
1
HUM icon
Humana
HUM
+$18.3M
2
OXY icon
Occidental Petroleum
OXY
+$16.5M
3
ABBV icon
AbbVie
ABBV
+$13.3M
4
CI icon
Cigna
CI
+$10.2M
5
ELV icon
Elevance Health
ELV
+$6.04M

Sector Composition

Rank Sector Weight
1 Healthcare 33.8%
2 Materials 29.05%
3 Energy 10.5%
4 Technology 2.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RETA
1
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$29.4M 31.55%
203,500
-18,500
-8% -$3.57M
NEM icon
2
Newmont
NEM
$124B
$15.8M 17.02%
350,000
– –
QQQ icon
3
Invesco QQQ Trust
QQQ
$481B
$11.4M 12.27%
+60,000
New +$12.7M
SPY icon
4
State Street SPDR S&P 500 ETF Trust
SPY
$809B
$9.65M 10.37%
+37,500
New +$11.4M
B
5
Barrick Mining
B
$67.9B
$9.16M 9.84%
500,000
– –
NVGS icon
6
Navigator Holdings
NVGS
$1.26B
$5.46M 5.87%
1,225,000
+201,700
+20% +$2.02M
EPSN icon
7
Epsilon Energy
EPSN
$180M
$2.9M 3.11%
1,085,000
– –
DHX icon
8
DHI Group
DHX
$166M
$2.42M 2.6%
1,122,556
-127,444
-10% -$342K
IRIX icon
9
IRIDEX
IRIX
$15.1M
$2.1M 2.25%
1,320,000
– –
CF icon
10
CF Industries
CF
$18.2B
$2.04M 2.19%
+75,000
New +$2.79M
PARR icon
11
Par Pacific Holdings
PARR
$3.9B
$1.42M 1.53%
200,000
– –
ESXB
12
DELISTED
Community Bankers Trust Corporation
ESXB
$1.21M 1.3%
250,000
– –
TUES
13
DELISTED
Tuesday Morning Corp
TUES
$95K 0.1%
163,709
– –
ABBV icon
14
AbbVie
ABBV
$440B
– –
-150,000
Closed -$13.3M
AEM icon
15
Agnico Eagle Mines
AEM
$93.8B
– –
-85,000
Closed -$5.24M
CI icon
16
Cigna
CI
$73.3B
– –
-50,000
Closed -$10.2M
ELV icon
17
Elevance Health
ELV
$86.6B
– –
-20,000
Closed -$6.04M
HUM icon
18
Humana
HUM
$46.7B
– –
-50,000
Closed -$18.3M
OXY icon
19
Occidental Petroleum
OXY
$58.5B
– –
-400,000
Closed -$16.5M
WPM icon
20
Wheaton Precious Metals
WPM
$61.3B
– –
-175,000
Closed -$5.21M
FOMX
21
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
– –
-10,000
Closed -$33K

Similar funds

TWM
Tripletail Wealth Management Orlando, Florida $73.4M AUM 26.64% 1-Year Est. Return
JCA
January Capital Advisors San Francisco, California $74.2M AUM
WH
Wallace Hart Lexington, Kentucky $72.6M AUM 34.63% 1-Year Est. Return
WPA
Winning Points Advisors Boca Raton, Florida $74.8M AUM
PWS
Pursuit Wealth Strategies Raleigh, North Carolina $72M AUM
SPC
Square Peg Capital Surry Hills, NSW, Australia $75.2M AUM 15.62% 1-Year Est. Return
OC
Owlhouse Capital New York $75.3M AUM
IVMX
Institutional Venture Management XV Menlo Park, California $75.5M AUM 16.43% 1-Year Est. Return

Paragon Associates & Paragon Associates II Joint Venture's Q1 2020 Portfolio in Review

As of Q1 2020, Paragon Associates & Paragon Associates II Joint Venture held 21 positions worth $93.1M, down 48% from $178M the previous quarter. Its ten largest holdings account for 97% of the portfolio.

Paragon Associates & Paragon Associates II Joint Venture withdrew a net $49.8M in Q1 2020, closing 8 positions and reducing 2 holdings. Its most notable exit was Humana, an estimated $18.3M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 34% of assets, down from 54% a quarter earlier, followed by Materials and Energy.

Against the trend, Paragon Associates & Paragon Associates II Joint Venture opened a new position in Invesco QQQ Trust worth $11.4M.

  • Paragon Associates & Paragon Associates II Joint Venture's largest Q1 2020 buy was Invesco QQQ Trust: 60,000 shares worth $11.4M.
  • Paragon Associates & Paragon Associates II Joint Venture added most to Navigator Holdings in Q1 2020, an estimated $2.02M increase.
  • Paragon Associates & Paragon Associates II Joint Venture's biggest Q1 2020 reduction was Reata Pharmaceuticals, Inc. Class A Common Stock, cutting an estimated $3.57M.
  • Paragon Associates & Paragon Associates II Joint Venture fully exited Humana in Q1 2020, selling an estimated $18.3M.
  • Paragon Associates & Paragon Associates II Joint Venture's ten largest holdings make up 97% of its $93.1M portfolio in Q1 2020.
  • Paragon Associates & Paragon Associates II Joint Venture opened 3 new positions and closed 8 in Q1 2020.
  • Paragon Associates & Paragon Associates II Joint Venture's portfolio value fell 48% quarter-over-quarter to $93.1M.

Based on Paragon Associates & Paragon Associates II Joint Venture's 13F filing for Q1 2020, filed 15 May 2020.